|
09 Dec 2019 |
Merck to Acquire ArQule, Advancing Leadership in Oncology
|
|
09 Dec 2019 |
Sanofi to acquire Synthorx to bolster its immuno-oncology pipeline for $2.5 Billion
|
|
09 Dec 2019 |
Healx Joins Forces with Boehringer Ingelheim to Discover New Treatment Approaches for Rare Neurological Diseases
|
|
08 Dec 2019 |
Denovo Biopharma Licenses Global Rights to a Novel Late-Stage Oncology Drug from Sunesis Pharmaceuticals
|
|
08 Dec 2019 |
Janssen to Acquire Investigational Bermekimab from XBiotech
|
|
06 Dec 2019 |
Cerecor to Acquire Aevi Genomic Medicine
|
|
04 Dec 2019 |
Gatehouse Bio collaborates with AstraZeneca to accelerate new drug discovery
|
|
03 Dec 2019 |
Astellas Enters into Definitive Agreement to Acquire Audentes Therapeutics
|
|
02 Dec 2019 |
Neurocrine Biosciences and Xenon Pharmaceuticals Announce Agreement to Develop First-in-Class Treatments for Epilepsy
|
|
02 Dec 2019 |
Samyang Biopharm USA, Inc and CanCure LLC Announce Global Strategic Collaboration to Advance Novel Immuno-Oncology Therapeutic
|
|
27 Nov 2019 |
Hoth Therapeutics and North Carolina State University Enter License Agreement for Gene Therapy
|
|
26 Nov 2019 |
Woolsey Pharmaceuticals Signs License Agreement With Asahi Kasei Pharma for Exclusive Rights to Fasudil
|
|
25 Nov 2019 |
Asahi Kasei Group Announces a Recommended Conditional Voluntary Public Offer for Veloxis
|
|
25 Nov 2019 |
Novartis to acquire The Medicines Company for USD 9.7 bn, adding inclisiran, a potentially transformational investigational cholesterol-lowering therapy to address leading global cause of death
|
|
21 Nov 2019 |
Vor Biopharma and MaxCyte Announce Clinical and Commercial License Agreement for Engineered Hematopoietic Stem Cells (eHSCs) to Treat Cancer
|
|
21 Nov 2019 |
ViiV Healthcare announces exclusive licensing agreement with the National Institutes of Health for investigational “bNAb” with potential for long-acting HIV treatment and prevention
|
|
21 Nov 2019 |
Harpoon Therapeutics and AbbVie Announce Licensing and Option Collaboration to Advance HPN217, Harpoon’s BCMA-Targeting TriTAC®, and Expand Existing Discovery Collaboration
|
|
21 Nov 2019 |
Appili Therapeutics Acquires Clinical Stage Antifungal Program From FUJIFILM Toyama Chemical
|
|
20 Nov 2019 |
Excelra Announces a Drug Repurposing Collaboration With Maruho On Dermatological Applications
|
|
20 Nov 2019 |
Dragonfly Therapeutics Announces Collaboration with AbbVie for Autoimmune Diseases and Oncology
|
|
19 Nov 2019 |
Vertex and Molecular Templates Establish Collaboration to Discover and Develop Novel Targeted Conditioning Regimens to Enhance Hematopoietic Stem Cell Transplants
|
|
19 Nov 2019 |
Zelluna Immunotherapy and Glycostem Therapeutics announce partnership to develop allogeneic TCR-NK therapies
|
|
19 Nov 2019 |
Idorsia enters into a collaboration with Antares for the development of a novel self-administered drug-device product for selatogrel
|
|
19 Nov 2019 |
Alkermes to Acquire Rodin Therapeutics
|
|
19 Nov 2019 |
Dicerna and Novo Nordisk Enter Agreement to Discover and Develop RNAi Therapies for Liver-Related Cardio-Metabolic Diseases
|
